Trevi reports positive results in skin condition trial
New Haven-based Trevi Therapeutics has reported positive results in a trial of its drug Haduvio for treatment of prurigo nodularis, a chronic inflammatory skin disease. Trevi CEO...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
New Haven-based Trevi Therapeutics has reported positive results in a trial of its drug Haduvio for treatment of prurigo nodularis, a chronic inflammatory skin disease. Trevi CEO...
Artizan Biosciences has inked a lease to occupy 10,000 square feet of Class A laboratory and office space at Winchester Works in New Haven. The New...
There’s an urgent need to improve and extend the lives of patients with rare neurodegenerative diseases, and the FDA is hoping a new five-year action...
View this email in your browser Weekly Roundup – June 23, 2022 The FDA has...
Connecticut Innovations (CI) invested $13.5 million across 34 transactions during the third quarter of its 2022 fiscal year. CI directed approximate ly $4.9 million toward...
Connecticut Children’s is undertaking the largest-ever expansion of its Hartford campus, as it prepares to grow existing services and launch new ones, including an effort...
As the Winchester Works life sciences building in New Haven nears full occupancy, the developer making over the former arms factory is building three smaller...
UConn has announced the recipients of the 2022-23 SPARK Technology Commercialization Fund Program. SPARK supports innovative proof-of-concept studies seeking to translate research discoveries into products,...
While the world continues to grapple with the impact of COVID-19, a different viral outbreak, monkeypox, is making headlines. Saad Omer, PhD, director of Yale...
Injured athletes looking to return to their sports need to regain not only their function, but also their strength, agility, and quickness, plus motivation and...